Author:
Abbasi Kasbi Naghmeh,Ghane Ezabadi Sajjad,Kohandel Kosar,Khodaie Faezeh,Sahraian Amir Hossein,Nikkhah Bahrami Sahar,Mohammadi Mahsa,Almasi-Hashiani Amir,Eskandarieh Sharareh,Sahraian Mohammad Ali
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Piggott T, Nonino F, Baldin E, Filippini G, Rijke N, Schünemann H, Laurson-Doube J. Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis. Multiple Scler J - Experimental Translational Clin. 2021;7(4):20552173211051855.
2. Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am. 2007;30(4):803–17.
3. Maroufi H, Mortazavi SH, Sahraian MA, Eskandarieh S. Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: a systematic review. Curr J Neurol. 2021;20(3):166–84.
4. Hellwig K, Verdun di Cantogno E, Sabidó M. A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis. Ther Adv Neurol Disord. 2021;14:17562864211051012.
5. Ghadiri F, Sahraian MA, Razazian N, Ashtari F, Poursadeghfard M, Nabavi SM, et al. Late-onset multiple sclerosis in Iran: a report on demographic and disease characteristics. Mult Scler Relat Disord. 2023;70:104493.